Methylnaltrexone
- TRADE NAME: Relistor (Wyeth)
- INDICATIONS: Treatment of opioid-induced constipation in patients with advanced illness and receiving palliative care
- CLASS: Opioid antagonist, Opioid receptor antagonist
- HALF-LIFE: 8 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
PREGNANCY CATEGORY: B
Contra-indicated in patients with known or suspected mechanical gastrointestinal obstruction.
Please login to see the rest of this drug profile
SKIN.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric